Introduction
von Willebrand (vW)l protein is a large, adhesive glycoprotein of complex multimeric structure that mediates the adhesion of platelets to subendothelium after injury (1) . The absence of, or structural defects in vW protein result in the bleeding disorder vW disease caused by inadequate platelet binding at the injured site (2, 3) . vW protein is synthesized by endothelial cells (4) , which are likely to be the source of vW protein in plasma and subendothelium. In the endothelial cells, vW protein is stored in the Weibel-Palade bodies (5), a situation that allows for rapid release of the protein upon stimulation. vW protein is first synthesized as a 260-kD precursor subunit that undergoes carbohydrate processing, disulfide bond formation to form large polymers, and proteolytic cleavage to the mature 220-kD subunit form (6, 7) . Small amounts of precursor with complex type carbohydrate are secreted (275 kD) along with the processed (220 kD) subunit (6) . While metabolically labeled, processed subunit has been purified from guinea pig megakaryocytes (8) , the synthesis of precursor subunit, details of the processing steps, and information regarding multimer formation by these cells have not been described. An even greater lack of information exists for human megakaryocyte-derived vW protein. This is probably due to difficulties encountered in obtaining a sufficient number of megakaryocytes from human bone marrow to perform metabolic labeling studies. In this report, we show that human micromegakaryocytes present in the peripheral blood of a patient with chronic myelogenous leukemia (CML) in blast transformation synthesize, process, and secrete vW protein. The Antisera. The preparation and characterization of antiserum used for immunofluorescence studies against human vW protein were as described previously (5) . Antiserum against platelet factor 4(10) and against platelet glycoproteins I, U~b, and 111a (11) Immunofluorescence. Fluorescence staining of buffy coat cells and of endothelial cells was carried out as previously described (5 Purification of vW protein. At the end of the labeling period buffy coat cells were removed from flasks and pelletized by centrifugation as before. Media was removed and saved, and cells were washed once with PBS. Buffy coat cells were vortexed vigorously after addition of the lysis buffer (6) . After lysing, the final concentration of ingredients was that of the radioimmunoprecipitation assay buffer used for washing the immunoprecipitate (12) . The cell lysate and culture medium samples were incubated with gelatin Sepharose for 1.5 hat room temperature to remove fibronectin and other contaminating proteins that adhere nonspecifically. The gelatin Sepharose was removed by centrifugation. Protein A-Sepharose CL4B (30 mg) (Sigma Chemical Co., St. Louis, MO) was preincubated with100 ul anti-vW protein antiserum for 30 min, then incubated with each sample for 1.5 h at room temperature. Protein A-Sepharose beads were washed extensively, then boiled in electrophoresis sample buffer (13) and analyzed by gel electrophoresis.
Electrophoresis gels. Sodium dodecyl sulfate (SDS)-polyacrylamide gels were prepared as described by Laemmli (13) . Agarose horizontal slab gels were prepared using a solution of 2% agarose and 0.2% SDS in 0.05 M phosphate buffer, pH 7.0. Densitometer scans ofautoradiograms of agarose gels were made, and areas under peaks were measured by weighing cutout traces of the scans.
Results
Immunofluorescence staining ofperipheral blood cells. Nucleated cells tentatively identified as micromegakaryocytes were seen in a Wright's stained preparation ofa peripheral blood film obtained from the patient under study during the accelerated phase of his illness (Fig. 1) . Immunofluorescence staining of the patient's buffy coat smears with anti-vW protein antiserum revealed positively stained nucleated cells (Fig. 2 a) . The granular pattern of staining was similar to that found in platelet alpha granules (Fig. 2, e and f), which are known to contain vW protein (14, 15) .
The cells that exhibited positive staining were distinctly different from stained smears of endothelial cells (Fig. 2 d) antiserum was observed in nucleated cells with varying nuclear/ cytoplasmic ratio, including those with only a very small rim of cytoplasm (Fig. 2 f) . The percentage of nucleated cells that stained brightly with anti-vW protein antiserum was 13%. No positively stained nucleated cells were seen in buffy coat smears from other patients with leukemia, two of whom had acute myelogenous leukemia and one of whom had acute lymphoblastic leukemia (not shown). No positive cells were seen when smears were stained with fluorescein isothiocyanate-conjugated antibody alone in the absence of anti-vW protein antiserum, indicating that positive staining was not due toFc receptors present on the cell surface (Fig. 2 b) .
Staining of buffy coat smears with antiplatelet factor 4 antiserum also showed cells with a granular staining pattern that was similar to that obtained with anti-vW protein antiserum (Fig. 2 g) . Bright, uniform (nongranular) staining was observed with antiserum against platelet glycoproteins (Fig. 2 h) . Endothelial cells did not stain positively with either antiplatelet factor 4 or antiplatelet glycoprotein antisera (not shown). There were significantly fewer nucleated cells in relation to platelets in buffy coat smears from normal volunteers, and none of the nucleated cells stained positively with anti-vW protein antiserum (Fig. 2   c) , antiplatelet factor 4, or antiplatelet glycoprotein antiserum (not shown). These results further confirmed that nucleated cells of megakaryocytic origin were present only in the peripheral blood of the patient with CML.
vWprotein biosynthesis. Buffy coats were prepared from peripheral blood samples of the patient under study was well as from the other patients with leukemia and from normal volunteers. Cells were counted and suspended as described in (Fig. 3 a) , but no adherent or spread cells that resembled endothelial cells (Fig. 3 b) were observed even after 6 d in culture. At the end of the 36-48-h labeling period, all culture media were collected and cells were lysed.
vW protein was immunopurified from the culture medium and cell lysates and analyzed on gels. In the buffy coat cultures, radiolabeled vW protein was detected only in the samples obtained from the CML patient, indicating that it was synthesized by the megakaryocytes. The vW protein subunit composition and migration on reduced polyacrylamide gels were indistinguishable from endothelial cell vW protein composition and migration (Fig. 4) . Both cell types synthesized the finished 220- Analysis of the nonreduced vW protein on agarose gels showed that the dimer and higher molecular weight multimers of vW protein from megakaryocytes migrated to the same positions in the gel as those from endothelial cells (Fig. 5) . However, we have observed slightly less dimer in comparison to the amount of higher molecular weight multimers in the megakaryocytes and in their secreted vW protein than was present within endothelial cells and in endothelial cell culture medium (Figs. 5 and 6).
Discussion
Immunofluorescence microscopy revealed the presence of vW protein in small and large nucleated cells in buffy coat smears from a patient with accelerated phase CML (Fig. 2 a, e, andf) , suggesting that the cells were ofmegakaryocytic origin. This was supported by positive staining ofthese cells with antisera against platelet factor 4 and against platelet glycoproteins (Fig. 2 g and  h) . The apearance of these megakaryocytic cells is not an uncommon occurrence in acute leukemia. A recent study showed that 12 patients with acute myelogenous leukemia, which represented 11.8% of the group studied, had circulating megakar- (Fig. 3 a) , making it unlikely that vW protein biosynthesis was due to the presence of endothelial cells. Buffy coats from normals and from the other leukemia patients contained no nucleated cells that stained positively with anti-vW protein antiserum, and their cultures revealed no biosynthesis of vW protein. Although the megakaryocyte-derived vW protein resembled that of endothelial cells, it contained relatively less dimer, supporting our conclusion that the vW protein synthesized by the CML patient buffy coat culture was not of endothelial origin. It is unlikely that platelets synthesized the vW protein since they possess only vestigial protein synthetic capacity and since control cultures containing platelets showed no such synthesis. Therefore, the synthesis ofvW protein by the buffy coat cultures from the patient studied was due to the presence of micromegakaryocytes.
The processing steps used by the megakaryocytes in the biosynthesis of vW protein are likely to be similar to those described for endothelial cells (7, 17) . Like endothelial cells, megakaryocytes contain an intracellular pool ofa 260-kD precursor subunit and a pool of dimer molecules. As for endothelial cells, some precursor of larger molecular size (275 kD) was secreted, suggesting that the difference between megakaryocyte intracellular and secreted precursor could also have been due to carbohydrate processing, as has been reported for endothelial cell precursor The dimer band represents 61% of the total area above the base line in megakaryocyte cell lysate (A), and 45% in megakaryocyte cell culture medium (B), whereas the dimer composes 81% and 58% of the total area in endothelial cell lysates (C) and endothelial cell culture medium (D), respectively. (17) . The presence ofmultimers in the megakaryocyte cell lysate suggests that the polymerization of vW protein was intracellular, as is the case for endothelial cells (6) . The same migration pattern of the polymers on nonreduced gels (Fig. 5) 
